aod9604 development discontinued 5mg | UK GH Fragment Research Peptide, ≥99% HPLC tested materials for laboratory and scientific research applications. AOD9604 6mg Growth Hormone Fragment

Professor Ngs research contributions to AOD-9604 development include: Synthesis and characterization of the modified C-terminal growth hormone fragment with enhanced stability Design of the tyrosine N-terminal modification to improve peptide stability and half-life Preclinical studies demonstrating lipolytic effects in obese animal models Advancement of the peptide through multiple phases of clinical development Investigation of mechanisms underlying beta-3-adrenergic receptor modulation His work established the foundation for understanding peptide-based approaches to metabolic regulation, though clinical translation ultimately proved unsuccessful

Participants received pharmaceutical-grade product with verified purity

The right choice depends entirely on your primary goal, whether its appetite control, direct fat mobilization, or systemic metabolic optimization

elevation suggests contamination or mislabeled product) Clinical Research Findings A comprehensive safety and tolerability analysis evaluated approximately 900 participants across six randomized, double-blind, placebo-controlled trials conducted between 2001-2006

Currently, excessive NNMT upregulation is implicated in several scenarios, including obesity, metabolic diseases, muscle cell degeneration, and even some types of cancer [2, 4]

Reconstituted peptides must be refrigerated immediately and used within 28 to 30 days